The current status of treatment-related severe hypoglycemia in Japanese patients with diabetes mellitus: a report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society

Namba M, Iwakura T, Nishimura R, et al. Current status of treatment-related severe hypoglycemia in Japanese patients with diabetes mellitus: report from the committee on a survey of severe hypoglycemia in Japan Diabetes Society. J Japan Diabet Soc. 2017;60:826–42 (Japanese).

Nakamura J, Kamiya H, Haneda M, et al. Cause of death in Japanese patients with diabetes based on the results of survey of 45,708 cases during 2001-2010. J Jpn Diabet Soc. 2016;59:667–84 (Japanese).

Hotta N, Nakamura J, Iwamoto Y, et al. A questionnaire survey on the causes of death in 18,385 Japanese patients with diabetes mellitus during the 10 years between 1991and 2000. J Japan Diabet Soc. 2007;50:47–61 (Japanese).

Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32:187–92.

Yaffe K, Falvey CM, Hamilton N, et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Int Med. 2013;173:1300–6.

Aung PP, Strachan WJ, Frier BM, et al. Severe hypoglycemia and late-life cognitive ability in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study. Diabet Med. 2012;29:328–36.

Statistics Bureau, Ministry of Internal Affairs and Communication of Japan. Number of emergency transportation services ordered for 2014 (flash report). 2015. http://www.fdma.go.jp/neuter/topics/houdou/h27/03/270331_houdou_2.pdf . (Japanese). Accessed 29 June 2017.

Ministry of Health, Labor and Welfare of Japan. Fact sheets from the 2014 Patient Survey. 2015. http://www.mhlw.go.jp/toukei/saikin/hw/kanja/14/index.html . (Japanese). Accessed 29 June 2017.

Shehab N, Lovegrove MC, Geller AI, et al. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. JAMA. 2016;316:2115–25.

Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med. 2014;174:678–86.

Japan Diabetes Society. Guidelines for the Management of Diabetes Mellitus 2016. Tokyo; Nankodo, 2016. (Japanese).

The International Hypoglycaemia Study Group. Glucose concentration of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of American Diabetes Association and the Europian Association for the Study of Diabetes. Diabetologia. 2017;60:3–6.

Hypoglycaemia UK. Study Group Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50:1140–7.

Huang ES, Laiteerapong N, Liu JY, et al. Rates of complications and mortality in older patients with diabetes mellitus. The Diabetes and Aging Study. JAMA Intern Med. 2010;174:251–8.

Holstein A, Hammer C, Hahn M, et al. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf. 2010;9:675–81.

Greco D, Pisciotta M, Gambina F, et al. Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older. Exp Clin Endocrinol Diabetes. 2010;118:215–9.

Yau CK, Eng C, Cenzer IS, et al. Glycosylated hemoglobin and functional decline in community-dwelling nursing home-eligible elderly adults with diabetes mellitus. J Am Geriatr Soc. 2012;60:1215–21.

Bramlage P, Gitt AK, Binz C, et al. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia. Cardiovasc Diabetol. 2012;11:122.

Iwakura T, Sasaki S, Fujiwara Y, et al. Analysis of 135 type 2 diabetic patients with treatment-associated severe hypoglycemia. J Japan Diabet Soc. 2012;55:857–65 (Japanese).

Japan Diabetes Society Committee on the Proper Use of Incretin-based Drugs (GLP-1 Receptor Agonists and DPP-4 Inhibitors): On the Proper Use of Incretin-based Drugs and Sulfonylureas (SUs) (April 15, 2010). http://www.nittokyo.or.jp/kinkyu_incretin100408m.html . (Japanese).

Japan Diabetes Society (2017) Japan Diabetes Society/Japan Geriatrics Society Joint Committee for Improving Treatments for Elderly Patients with Diabetes Mellitus: glycemic control goals for elderly patients with diabetes mellitus. Diabetes Treatment Guide 2016-2017. Tokyo; Bunkodo, 2016. (Japanese).

Oishi M, Yamazaki K, Okuguchi F, et al. Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32). J Diabetes Investig. 2014;5:581–7.

Kuroda A, Kaneto H, Kawashima S, et al. Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus. J Diabetes Investig. 2013;4:78–81.

DeZoysa N, Roqers H, Standler M, et al. A psychoeducational program to restore hypoglycemia awareness: the DAFNE-HART pilot study. Diabetes Care. 2014;37:863–6.

Geddes J, Schopman JE, Zammitt NN, Fisher BM. Prevalence of impaired awareness of hypoglycemia in adults with type 1 diabetes. Diabetes Med. 2008;25:501–4.

Schopman JE, Geddes J, Fisher BM. Prevalence of impaired awareness of hypoglycemia and frequency of hypoglycemia in insulin-treated type 2 diabetes. Diabetes Res Clin Pract. 2010;87:64–8.

Cryer PE. Mechanism of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54:3592–601.

Meyer C, Grossmann R, Mitrakou A, et al. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care. 1998;21:1960–6.

Olsen SE, Biorgaas MR, Asvoid BO, et al. Impaired awareness of hypoglycemia in adults with type 1 diabetes is not associated with autonomic dysfunction or peripheral neuropathy. Diabetes Care. 2016;39:426–33.

Feinkohl I, Aung PP, Keller M, et al. Severe hypoglycemia and cognitive decline in older patients with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care. 2014;37:507–15.

Gruden G, Giunti S, Barutta F, et al. QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM Complications Study. Diabetes Care. 2012;35:125–7.

Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363:1410–8.

Hsu PF, Sung SH, Cheng HM, et al. Association of clinical symptomatic hypoglycemia with cardiovascular events and total-mortality in type 2 diabetes. Diabetes Care. 2013;36:894–900.

Redelmeier DA, Kenshole AB, Ray JG. Motor vehicle crashes in diabetic patients with tight glycemic control: a population-based case control analysis. PLoS Med. 2009;12:e1000192.